Trials / Completed
CompletedNCT00872885
Bunionectomy Trial With GRT6005
A Randomized, Phase IIa Trial Evaluating the Safety and Efficacy of a New Centrally Acting Analgesic in Subjects With Moderate to Severe Pain Following Bunionectomy.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 258 (actual)
- Sponsor
- Tris Pharma, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the trial is to determine whether the new centrally acting analgesic is effective in comparison to placebo and an active comparator (morphine).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GRT6005 | liquid formulation, 200 to 600 µg, single dose, one day |
| DRUG | Morphine | 60 mg |
| DRUG | Placebo | single dosage |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2009-08-01
- Completion
- 2009-10-01
- First posted
- 2009-03-31
- Last updated
- 2021-07-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00872885. Inclusion in this directory is not an endorsement.